Keywords: eu, clears, lilly, forsteo, osteoporosis, european, commission

EU clears Lilly's Forsteo for osteoporosis

Article | 30 June 2003

Print This

The European Commission has approved the use of Eli Lilly's Forsteo (teriparatide) for the treatment of osteoporosis in postmenopausal women. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in